Answers are grounded in this paper and cite their sources.
Therapy resistance remains a huge challenge for current breast cancer treatments. Exploring molecular mechanisms of therapy resistance might provide therapeutic targets for patients with advanced breast cancer and improve their prognosis. RNA-binding proteins (RBPs) play an important role in regulating therapy resistance. Here we summarize the functions of RBPs, highlight their tremendously important roles in regulating therapy sensitivity and resistance and we also reveal current therapeutic approaches reversing abnormal functions of RBPs in breast cancer.
No takes yet. Share an insight, caveat, or question.
Cen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: